Cargando…
Genetic Variation of the IL-28B Promoter Affecting Gene Expression
The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-α (PEG-IFNα) and ribavirin (RBV). The treatment achieves a sustained viral clearance in only approximately 50% of patients. Recent whole genome association studies revealed that single nucleotide polymorphi...
Autores principales: | Sugiyama, Masaya, Tanaka, Yasuhito, Wakita, Takaji, Nakanishi, Makoto, Mizokami, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201970/ https://www.ncbi.nlm.nih.gov/pubmed/22046316 http://dx.doi.org/10.1371/journal.pone.0026620 |
Ejemplares similares
-
Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
por: Iwamoto, Masashi, et al.
Publicado: (2017) -
Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene
por: Watanabe, Tsunamasa, et al.
Publicado: (2013) -
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
por: Watashi, Koichi, et al.
Publicado: (2014) -
IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan
por: Khudayberganova, Dinara, et al.
Publicado: (2014) -
Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015)